Physician profile
Debbie Palmer
NPI 1700857323
$3,836.69
in general payments reported to CMS, 2019-2025
19 companies · $225 in 2025
The $225 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,033 · 2020: $512 · 2021: $719 · 2022: $246 · 2023: $628 · 2024: $474 · 2025: $225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,326.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,326.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $1,913.10 | 2019-2025 | Aklief, Epsolay, Oracea |
| Medimetriks Pharmaceuticals, INC. | $350.00 | 2021 | |
| Leo Pharma INC. | $312.51 | 2019-2025 | Anzupgo |
| Dermavant Sciences, INC. | $258.17 | 2022-2024 | Vtama |
| Abbvie INC. | $236.49 | 2019-2025 | |
| Allergan, INC. | $158.54 | 2019-2022 | |
| Lumenis Be INC | $127.45 | 2023 | M22 |
| Vyne Pharmaceuticals INC. | $75.62 | 2020-2021 | |
| Botanix Sb INC | $65.19 | 2025 | Sofdra |
| Pfizer INC. | $65.16 | 2022-2024 | |
| Fidia Pharma USA INC. | $61.12 | 2024 | |
| Mayne Pharma Commercial LLC | $47.42 | 2025 | |
| Incyte Corporation | $37.71 | 2024 | Opzelura |
| Regeneron Healthcare Solutions, INC. | $24.13 | 2021 | |
| Almirall LLC | $23.78 | 2023 | Seysara |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $21.95 | 2023 | Otezla |
| Dermira, INC. | $21.70 | 2020 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $20.68 | 2022 | |
| Verrica Pharmaceuticals INC. | $15.97 | 2025 | Ycanth |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Debbie Palmer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.